Nicholas Investment Partners, LP - OREXIGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$1,310,000
-71.3%
1,903,000
-61.2%
0.09%
-67.8%
Q2 2015$4,563,000
-15.1%
4,903,000
+5.0%
0.29%
-13.1%
Q1 2015$5,377,000
-14.1%
4,668,000
-25.9%
0.34%
-14.1%
Q4 2014$6,261,0006,300,0000.39%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 9,826,000$2,358,0001.48%
SILVERBACK ASSET MANAGEMENT LLC 12,000,000$3,300,0001.00%
BVF INC/IL 10,000,000$2,650,0000.50%
Partner Investment Management, L.P. 403,000$111,0000.16%
PFM Health Sciences, LP 16,072,000$4,446,0000.13%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 21,414,000$5,934,000,0000.09%
Verition Fund Management LLC 2,066,000$547,0000.06%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 10,653,000$2,943,0000.05%
WOLVERINE ASSET MANAGEMENT LLC 6,000,000$1,623,0000.02%
Orbimed Advisors 5,210,000$1,441,0000.02%
View complete list of OREXIGEN THERAPEUTICS INC shareholders